BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37145426)

  • 1. Initial Presentation and Outcomes of Testicular Cancer among Different Racial and Ethnic Groups at a Tertiary Care Facility in New Mexico.
    Webster BR; Riley JM; Davis MS
    Urol Pract; 2021 Jan; 8(1):71-77. PubMed ID: 37145426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
    Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
    J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
    Donohue JP; Thornhill JA; Foster RS; Bihrle R; Rowland RG; Einhorn LH
    J Urol; 1995 Jan; 153(1):85-9. PubMed ID: 7966799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance--a decision analysis.
    Langenstroer P; Rosen MA; Griebling TL; Thrasher JB
    J Urol; 2002 Oct; 168(4 Pt 1):1396-401. PubMed ID: 12352401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
    Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
    J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
    Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
    J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: A population-based study.
    Bhambhvani HP; Greenberg DR; Kasman AM; DeRouen MC; Cheng I; Eisenberg ML; Shah SA
    Urol Oncol; 2021 Mar; 39(3):197.e1-197.e8. PubMed ID: 33423934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer.
    Patel HV; Srivastava A; Kim S; Patel HD; Pierorazio PM; Bagrodia A; Masterson TA; Ghodoussipour SB; Kim IY; Singer EA; Jang TL
    J Urol; 2022 May; 207(5):1057-1066. PubMed ID: 34978466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer.
    Radadia KD; Farber NJ; Tabakin AL; Wang W; Patel HV; Polotti CF; Weiss RE; Elsamra SE; Kim IY; Singer EA; Stein MN; Mayer TM; Jang TL
    J Clin Urol; 2019 Mar; 12(2):122-128. PubMed ID: 30854207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.
    Rice KR; Beck SD; Bihrle R; Cary KC; Einhorn LH; Foster RS
    J Urol; 2014 Nov; 192(5):1397-402. PubMed ID: 24813309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.
    Patel HD; Joice GA; Schwen ZR; Semerjian A; Alam R; Srivastava A; Allaf ME; Pierorazio PM
    World J Urol; 2018 Jan; 36(1):73-78. PubMed ID: 29026972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.